Liming Mao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Top Venues

Molecules (Basel, Switzerland)

Proceedings of the National Academy of Sciences of the United States of America

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Yao, Yongchao Liu, Qiuyun Xu, Liming Mao
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 29 (2) (2024)
Yuan Yao, Yongchao Liu, Qiuyun Xu, Liming Mao
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 29 (2) (2024)
Yuan Yao, Yongchao Liu, Qiuyun Xu, Liming Mao
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 29 (2) (2024)
Yuan Yao, Yongchao Liu, Qiuyun Xu, Liming Mao
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 29 (2) (2024)
Yunhan Wang, Boyu Zhang, Zongying Zhang, Jia Ge, Lin Xu, Jiawei Mao, Xiaorong Zhou, Liming Mao, Qiuyun Xu, Mengmeng Sang
Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity. Genes 14 (11) (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Zongying Zhang, Yunhan Wang, Qiuyun Xu, Xiaorong Zhou, Yong Ling, Jie Zhang, Liming Mao
Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Yunhan Wang, Yu Zhao, Zongying Zhang, Jie Zhang, Qiuyun Xu, Xiaorong Zhou, Liming Mao
High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity. Genes 14 (7) (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Jian-Ya Peng, Zeng-Xin Qi, Qi Yan, Xiu-Juan Fan, Kang-Li Shen, Hui-Wei Huang, Jian-Hua Lu, Xiao-Qin Wang, Xiao-Xia Fang, Liming Mao, Jianguang Ni, Liang Chen, Qian-Xing Zhuang
Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus-thalamus circuitry. Proceedings of the National Academy of Sciences of the United States of America 120 (17) (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Qiuyun Xu, Xiaorong Zhou, Warren Strober, Liming Mao
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 26 (6) (2021)